Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist

Clinical Chemistry

Volumn 50, Issue 6, 2004, Pages 1068-1071

  Kristensen, Gunn B B ^a   Nerhus, Kari ^a   Thue, Geir ^a   Sandberg, Sverre ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; QUALITY CONTROL; STATISTICAL SIGNIFICANCE;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; LABORATORY PERSONNEL; REFERENCE STANDARDS;

EID: 2642541633     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.031575     Document Type: Article

References (16)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
3. Thayer A. Deciphering diseases. Chem Eng News 1999;30:19-28.
4. Center for Devices and Radiological Health (CDRH). Human factors in self-monitoring of blood glucose: Task IV report, Vol. 1. Rockville, MD: US Food and Drug Administration, April 1990.
5. International Organization for Standardization. In vitro diagnostic test systems - requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO/TC 212/SC. Final Draft International Standard ISO/FDIS 15197. Geneva, Switzerland: ISO, 2003.
6. Burnett RW. Accurate estimation of standard deviations for quantitative methods used in clinical chemistry. Clin Chem 1975;21:1935-8.
7. National Committee for Clinical Laboratory Standards. Point-of-care blood-glucose testing in acute and chronic care facilities; approved guideline, 2nd ed. NCCLS document C30-A2. Wayne, PA: NCCLS, 2002.
8. American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care 1987;10:95-9.
9. American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care 1996;19:S62-6.
10. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 2001;47:209-14.
11. Skeie S, Thue G, Sandberg S. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clin Chem 2001;47:67-73.
12. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 2002;48:994-1003.
13. Proposed strategies for reducing user error in capillary blood glucose monitoring. The National Steering Committee for Quality Assurance in Capillary Blood Glucose Monitoring. Diabetes Care 1993;16:493-8.
14. One J. Standardization and recommendations for the appropriate use of automated devices for self-monitoring blood glucose: Rinsho Byori 2001;49:1190-8.
15. Barcelo A, Robles S, White F, Jadue L, Vega J. [An intervention to improve diabetes control in Chile]. Rev Panam Salud Publica 2001;10:328-33.
16. Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, et al. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study. Diabetes Metab 2001;27:681-7.